A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH
Clinical trial NCT03315507 · COMPLETED
Trial details
- NCT number
- NCT03315507
- Sponsor
- PhaseBio Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-20
- Primary completion
- 2019-08-08
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.